AKT2 and cancer: Interestingly, AKT2 Ser128 was appeared in almost all of these identified pathways in CAFs #1 treated with defactinib (10 μM), and the upregulated CCTα Ser315/319/323 sites existed in choline metabolism in cancer (KEGG ID: hsa05231) (Fig. 4a).